Iroko Pharmaceuticals
In the short period since Iroko was founded in 2007, we have assembled a portfolio of proven pharmaceuticals, especially prescription pain medicines. Our goal has been to bring new life to these trusted products—new geographic markets, new indications, and new benefits through further development enabled by new technology. We have already extended a distribution and sales network across more than 40 countries. And we have developed an industry-leading pipeline of nano-formulated lower-dose NSAIDs to address the need for new options in pain management. Experience. Marketed products. A global presence. Innovation. That’s Iroko. We’re an established company. And we’re hurrying to improve healthcare.
Domain
iroko.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$140.0M
Founded
2006
Tech Stack (32 technologies)
Frequently Asked Questions
What technologies does Iroko Pharmaceuticals use?+
Iroko Pharmaceuticals uses 32 technologies including Axeptio, Chart.js, Contentsquare.
What industry is Iroko Pharmaceuticals in?+
Iroko Pharmaceuticals operates in the Biotechnology industry.
Where is Iroko Pharmaceuticals based?+
Iroko Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026